This NICE guideline covers diagnosing and managing dementia (including Alzheimer’s disease). It aims to improve care by making recommendations on training staff and helping carers to support people living with dementia.
This guideline makes evidence-based recommendations aiming to support the following areas of practice:
- coordinating care and support between different services
- what support carers need, and how this should be provided
- staff training.
The guideline also makes recommendations on dementia diagnosis, based on a review of the latest evidence.
Read more and download the guideline at https://www.nice.org.uk/guidance/ng97
This guideline is an update of the NICE guideline on dementia (CG42, published November 2006) and replaces it. It also replaces recommendation 1.3 in the NICE technology appraisal guidance on donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (TA217).
NICE has also produced a guideline on mid-life approaches to delay or prevent the onset of dementia.
This guideline includes recommendations on:
- involving people living with dementia in decisions about their care
- assessment and diagnosis
- interventions to promote cognition, independence and wellbeing
- pharmacological interventions
- managing non-cognitive symptoms
- supporting carers
- staff training and education
Who is it for?
- Healthcare and social care professionals caring for and supporting people living with dementia
- Commissioners and providers of dementia health and social care services
- Housing associations, private and voluntary organisations contracted by the NHS or social services to provide care for people living with dementia
- People living with dementia, their families and carers